Development of an innovative real world evidence registry for the herpes simplex Virus: a case study
File(s)pdf (1).pdf (96.31 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Background: Infection with the Herpes Simplex Virus is common but is not well understood and stigmatised. Whilst a considerable number of people experience mild to severe physical symptoms after infection, only one sub-effective drug is available for treatment. A registry collecting real world data reported by people with the Herpes Simplex Virus could help them manage their condition, facilitate research into a vaccine, better treatment, and the impact of herpes on other conditions.
Objective: This paper reports on the development a registry to collect real world data reported by people with the Herpes Simplex Virus.
Methods: A case study design was selected to support a systematic means of observing the subject of investigation. The case study followed seven stages: plan, design, prepare, collect, analyse, create and share. We carried out semi-structured interviews with experts, thematically analysed the findings and built use cases. These will be used to generate detailed models of how a real world evidence registry might look, feel, and operate for different users.
Results: We found the following key themes in the interviews: 1) stigma and anonymity; 2) selection bias; 3) understanding treatment and outcome gaps; 4) lifestyle factors; 5) individualised vs population-level; and 6) severe complications of herpes simplex virus. We developed use cases for different types of patients, members of the public, researchers and clinicians for a herpes simplex virus registry.
Conclusions: This case study showed insights for the development of an appropriate registry to collect real world data reported by people with the Herpes Simplex Virus. Further research is needed on developing and testing the registry with different users and evaluate its feasibility and effectiveness of collecting data to support symptom management, and the development of vaccines and better treatment.
Objective: This paper reports on the development a registry to collect real world data reported by people with the Herpes Simplex Virus.
Methods: A case study design was selected to support a systematic means of observing the subject of investigation. The case study followed seven stages: plan, design, prepare, collect, analyse, create and share. We carried out semi-structured interviews with experts, thematically analysed the findings and built use cases. These will be used to generate detailed models of how a real world evidence registry might look, feel, and operate for different users.
Results: We found the following key themes in the interviews: 1) stigma and anonymity; 2) selection bias; 3) understanding treatment and outcome gaps; 4) lifestyle factors; 5) individualised vs population-level; and 6) severe complications of herpes simplex virus. We developed use cases for different types of patients, members of the public, researchers and clinicians for a herpes simplex virus registry.
Conclusions: This case study showed insights for the development of an appropriate registry to collect real world data reported by people with the Herpes Simplex Virus. Further research is needed on developing and testing the registry with different users and evaluate its feasibility and effectiveness of collecting data to support symptom management, and the development of vaccines and better treatment.
Date Issued
2020-03-12
Date Acceptance
2020-01-24
Citation
JMIR Dermatology, 2020, 3 (1), pp.1-10
ISSN
2562-0959
Publisher
JMIR Publications
Start Page
1
End Page
10
Journal / Book Title
JMIR Dermatology
Volume
3
Issue
1
Copyright Statement
©Michelle Helena van Velthoven, Ching Lam, Caroline de Cock, Terese Stenfors, Hassan Chaudhury, Edward Meinert. Originally
published in JMIR Dermatology (http://derma.jmir.org), 12.03.2020. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work, first published in JMIR Dermatology Research, is
properly cited. The complete bibliographic information, a link to the original publication on http://derma.jmir.org, as well as this
copyright and license information must be included.
published in JMIR Dermatology (http://derma.jmir.org), 12.03.2020. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work, first published in JMIR Dermatology Research, is
properly cited. The complete bibliographic information, a link to the original publication on http://derma.jmir.org, as well as this
copyright and license information must be included.
Sponsor
European Institute of Innovation and Technology
Identifier
https://derma.jmir.org/2020/1/e16933/
Publication Status
Published
Date Publish Online
2020-03-12